// App-Quantinova.ai

P162 : Biosamples from VEDOSS patients show classic pathological signs of Scleroderma:Opportunity for a biological diagnosis of disease

Researchers

Presenter

  • Rebecca L Ross

Principal Investigators

  • Emily Clarke

  • Will Merchant

  • Ioanna Georgiou

  • Panji Mulipa

  • Antonio Carriero

  • Giuseppina Abignano

  • Ariane Herrick

  • Christopher Denton

  • Natalia Riobo-Del Galdo

  • Francesco Del Galdo

Medical Centers

  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals, NHS Trust, Chapel Allerton Hospital, Leeds, UNITED KINGDOM

  • Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, Potenza, Italy

  • Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom

  • Division of Musculoskeletal & Dermatological Sciences, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UNITED KINGDOM

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • School of Molecular and Cellular Biology, Faculty of Biological Sciences, university of leeds, Leeds, United Kingdom

  • Department of Rheumatology, UCL Division of Medicine, London, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Cluster of differentiation 45

Drug/Treatment

  • IFN-lambda

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved